Loading provider…
Loading provider…
Gastroenterology Physician in Dayton, OH
NPI: 1003043647Primary Practice Location
Dayton Gastroenterology -Beavercreek (Sylvania)
75 Sylvania Dr, Dayton, OH
Primary Employer
Digestive Disease Consultants
daytongastro.com
HQ Phone
Get D.O. Michael's Phone Numberphone_androidMobile
Get D.O. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License

American Board of Internal Medicine
Gastroenterology

American Board of Internal Medicine
Internal Medicine
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 121 | 122 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 83 | 107 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 81 | 103 |
| 4 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 70 | 72 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 66 | 66 |
Models in the balance: evidence-based medicine versus evidence-informed individualized care.
Authors: Miles, Andrew, Loughlin, Michael
Journal: J Eval Clin Pract
Theory, experience and practice.
Authors: Loughlin, Michael, Fuller, Jonathan, Bluhm, Robyn, Buetow, Stephen, Borgerson, Kirstin
Journal: J Eval Clin Pract
Treating real people: Science and humanity.
Authors: Loughlin, Michael, Mercuri, Mathew, Pârvan, Alexandra, Copeland, Samantha Marie, Tonelli, Mark, Buetow, Stephen
Journal: J Eval Clin Pract
Publication Date: 2018-08-30
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Enzalutamide, DRUG: Abiraterone, DRUG: JSB462
Lead Sponsor: University of Malaya
Intervention / Treatment: DEVICE: Conventional TBA, DEVICE: 3D TBA
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA